NCT02691130
- Conditions
- Healthy, Infections, Influenza, +6 more
- Locations
-
- St Istvan St laszlo Hospital Budapest, Hungary
Clinical trial condition
Influenza
Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.
1,207 public trials
47 recruiting studies
Influenza trial results
NCT02553343
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Milford, Connecticut, United States
- Coral Gables, Florida, United States
- Wichita, Kansas, United States
- St Louis, Missouri, United States
NCT03035396
- Conditions
- Flu, Infections, Influenza, +6 more
- Locations
-
- University Health Care Center Syracuse, New York, United States
NCT03248960
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Ochre Health Medical Centre Casey Casey, Australian Capital Territory, Australia
- Paratus Clinical Blacktown Trial Clinic Blacktown, New South Wales, Australia
- Paratus Clinical Kanwal Trial Clinic Kanwal, New South Wales, Australia
- Coastal Family Health Buddina, Queensland, Australia
NCT00996853
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom
- GSK Investigational Site Watford, Hertfordshire, United Kingdom
- GSK Investigational Site Canterbury, Kent, United Kingdom
- GSK Investigational Site Blackburn, Lancashire, United Kingdom
NCT01747148
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01455753
- Conditions
- Human, Infections, Influenza, +6 more
- Locations
-
- Express Scripts St Louis, Missouri, United States
NCT00985088
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Jacksonville, Florida, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Meridian, Idaho, United States
Completed
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
NCT00976820
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Conway, Arkansas, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site San Francisco, California, United States
NCT01239537
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Bristol Children's Vaccine Centre, University of Bristol Bristol, United Kingdom
- Royal Devon and Exeter NHS Foundation Trust Exeter, United Kingdom
- St George's Vaccine Institute, University of London London, United Kingdom
- Oxford Vaccine Group, University of Oxford Oxford, United Kingdom